Bruno A. Costa, Palliative Care Fellow at Mount Sinai Health System, posted on X:
“Outstanding presentation by Tarek Mouhieddine from The Tisch Cancer Institute on combined PD-1 and Tim-3 blockade to enhance anti-myeloma T cell activity in patients receiving talquetamab.
Translational insights into GPRC5D and T cell dynamics during BsAb therapy with exciting clinical applicability.”
